
### [MONDO:0003193](http://purl.obolibrary.org/obo/MONDO_0003193)
**Label:** bile duct adenocarcinoma

**Subclasses:** [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), 

**Corr. equiv. classes:** [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [OMIM:615619](http://purl.obolibrary.org/obo/OMIM_615619), 

**Class expressions from DL-Learner:**

- [HP:0100574](http://purl.obolibrary.org/obo/HP_0100574) (Biliary tract neoplasm) 76.73%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001438](http://purl.obolibrary.org/obo/HP_0001438) (Abnormality of abdomen morphology))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis))) 75.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 75.00%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) 55.77%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) 53.87%


